178 related articles for article (PubMed ID: 7042056)
1. The Schild regression in the process of receptor classification.
Kenakin TP
Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
[TBL] [Abstract][Full Text] [Related]
2. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
Cheng HC
Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
[TBL] [Abstract][Full Text] [Related]
3. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
Kenakin TP
Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
[TBL] [Abstract][Full Text] [Related]
4. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations.
Cheng HC
J Pharmacol Toxicol Methods; 2001; 46(2):61-71. PubMed ID: 12481843
[TBL] [Abstract][Full Text] [Related]
5. Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.
Pöch G; Brunner F; Kühberger E
Br J Pharmacol; 1992 Jul; 106(3):710-6. PubMed ID: 1504755
[TBL] [Abstract][Full Text] [Related]
6. The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processes.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1981 Oct; 219(1):112-20. PubMed ID: 7288599
[TBL] [Abstract][Full Text] [Related]
7. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
8. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
Calderone V; Baragatti B; Breschi MC; Martinotti E
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
[TBL] [Abstract][Full Text] [Related]
9. The use of drug-receptor affinity measures in the differentiation of receptors.
Tallarida RJ
Fed Proc; 1982 May; 41(7):2323-7. PubMed ID: 6122613
[TBL] [Abstract][Full Text] [Related]
10. The effects on Schild regressions of antagonist removal from the receptor compartment by a saturable process.
Kenakin TP; Beek D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):103-8. PubMed ID: 3561525
[TBL] [Abstract][Full Text] [Related]
11. Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation.
Ezechiáš M; Cajthaml T
Toxicology; 2019 May; 420():21-28. PubMed ID: 30935971
[TBL] [Abstract][Full Text] [Related]
12. Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.
Leff P; Wood BE; O'Connor SE
Br J Pharmacol; 1990 Nov; 101(3):645-9. PubMed ID: 2076483
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.
Belz GG
Br J Clin Pharmacol; 2003 Jul; 56(1):3-10. PubMed ID: 12848769
[TBL] [Abstract][Full Text] [Related]
14. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Hussain MB; Marshall I
Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
[TBL] [Abstract][Full Text] [Related]
15. Receptor theories and quantitative effect versus dose-concentration relationship.
Tallarida RJ
Drug Metab Rev; 1984; 15(1-2):345-63. PubMed ID: 6745084
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the effects of alpha 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery.
Van der Graaf PH; Shankley NP; Black JW
Br J Pharmacol; 1996 Jul; 118(5):1308-16. PubMed ID: 8818358
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta.
Van der Graaf PH; Shankley NP; Black JW
Br J Pharmacol; 1996 May; 118(2):299-310. PubMed ID: 8735631
[TBL] [Abstract][Full Text] [Related]
18. An alternative method to evaluate the nature of an antagonist and its potency: a theoretical approach.
Calderone V
J Pharmacol Toxicol Methods; 1998 Apr; 39(3):129-35. PubMed ID: 9741386
[TBL] [Abstract][Full Text] [Related]
19. Why the Schild method is better than Schild realised.
Colquhoun D
Trends Pharmacol Sci; 2007 Dec; 28(12):608-14. PubMed ID: 18023486
[TBL] [Abstract][Full Text] [Related]
20. RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH
Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
